Evidence map›Paper›PMID 41558667›Full record

Observational studyThe journal of applied laboratory medicine2026

Cardiac Troponin Thresholds in Children and Young Adults: A Multi-Center Cohort Study.

Alexander J F Thurston, Eirik Å Røys, Ragnhild Røysland, Øyvind Skadberg, Fabienne Decrue, Dorien M Kimenai, Nicholas L Mills, Kristin M Aakre

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in The journal of applied laboratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexander J F ThurstonBHF Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-1024-7651
Eirik Å RøysDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Ragnhild RøyslandMultidisciplinary Laboratory Medicine and Medical Biochemistry, Division of Diagnostics and Technology, Akershus University Hospital, Lørenskog, Norway.
Øyvind SkadbergLaboratory of Medical Biochemistry, Stavanger University Hospital, Stavanger, Norway.
Fabienne DecrueBHF Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, United Kingdom.
Dorien M KimenaiBHF Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0003-1591-1352
Nicholas L MillsBHF Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0003-0533-7991
Kristin M AakreDepartment of Clinical Science, University of Bergen, Bergen, Norway.ORCID 0000-0002-7340-6736

Funding

British Heart Foundation FS/CRTF/25/24735British Heart Foundation FS/IBSRF/23/25161British Heart Foundation RE/24/130012Norway Regional Health Authority F-12821Research Excellence Award CH/F/21/90010Research Excellence Award RE/24/130012Research Excellence Award RG/20/10/34966Western Norway Regional Health Authority F-12976
6 · The paper itself

Abstract

backgroundThe role of high-sensitivity cardiac troponin (cTn) assays for children and young adults is uncertain, and no guidance is available on diagnostic thresholds. This study evaluates the effect of applying pediatric compared to adult upper reference limits (URLs) for cTn.

methodsWe carried out a retrospective multicenter international cohort study of consecutive children and young adults (1 day to 18 years) undergoing cTn I or T testing at 4 tertiary care hospitals in Norway and Scotland, United Kingdom, from 2013 to 2023. Myocardial injury was classified using the adult sex-specific 99th percentile URL, a pediatric sex-specific 99th percentile, and a pediatric sex-specific 97.5th percentile. Diagnoses of myocarditis were obtained from the Norwegian Patient Register and the Scottish Morbidity Record.

resultsIn total, 9833 (46.6% female) children and young adults underwent cTn testing. Applying the adult sex-specific 99th percentile, 1771 (18.0% [95% CI, 17.3%-18.8%]) had myocardial injury compared with 1762 (17.9% [95% CI, 17.2%-18.7%]) using a pediatric 99th percentile. In contrast, applying a pediatric sex-specific 97.5th percentile would identify 2261 (23.0% [95% CI, 22.2%-23.8%]) with myocardial injury (a 28% relative increase). Infants had a higher frequency of myocardial injury than those 1-18 years old (1035/1104; 93.8% [95% CI, 92.2%-95.1%] vs 1226/8729; 14.0% [95% CI, 13.3%-14.8%] using pediatric sex-specific 97.5th percentile, P < 0.001). Testing for cTn increased over the study period (τ = 0.42, P < 0.001).

conclusionsThe use of pediatric-specific 97.5th percentile URLs for cTn would increase classification of myocardial injury in children and young adults. The clinical implications of this are uncertain and require further study given cTn testing has increased over the last decade.

Indexed as

MyocarditisTroponin ITroponin TAdolescentBiomarkersChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleNorwayReference ValuesRetrospective StudiesScotlandBiomarkersTroponin ITroponin T

Identifiers

PMID41558667
PMCPMC13141673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.